A Drug Discovery Scientist is central to the early stages of developing new therapeutic agents that target specific diseases. Their work begins by identifying promising biological targets—such as proteins, enzymes, or genes—linked to a disease pathway. Once a target is validated, these scientists screen libraries of chemical or biological compounds to find those with the potential to interact effectively and selectively. Advanced tools like high-throughput screening, molecular modeling, and bioinformatics assist in narrowing down viable candidates. The selected hits are then optimized through medicinal chemistry to improve their efficacy, selectivity, and safety profiles. This foundational research sets the stage for transforming a compound into a potential drug candidate.
Collaboration is essential in this role, as Drug Discovery Scientists work closely with biologists, chemists, toxicologists, and data analysts to evaluate how compounds behave in biological systems. They study pharmacodynamics, pharmacokinetics, and toxicity profiles to ensure that a candidate is not only active but also safe for progression. This position demands a strong understanding of disease mechanisms, structure-activity relationships, and the latest scientific technologies. With the growing influence of AI and machine learning, the field is becoming increasingly data-driven, enhancing precision and speed in discovering new therapies. Ultimately, their efforts help bridge the gap between theoretical research and the development of life-changing treatments.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India